I sat down with Dr. Tony Mok to tell us what we need to know about the seven year update of the Phase 3 CROWN study for advanced ALK-positive non-small cell lung cancer (NSCLC) presented at ASCO.
I sat down with Dr. Sarah Goldberg to talk about the COPERNICUS Study for patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC) abstract she presented at ASCO.